Biotechnology Market Size, Share & Trends Analysis Report By Technology (DNA Sequencing, Nanobiotechnology), By Application (Health, Bioinformatics), By Region, And Segment Forecasts, 2021 - 2028

Biotechnology Market Growth Growth & Trends Trends

he global biotechnology market size is expected to reach USD 2.44 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology.

Robust funding through alliance investment in start-up biotechnology companies for adopting new and advanced products is contributing to market growth. For instance, in February 2021, Illumina, Inc. invested in nine new genomics companies through Illumina Accelerator in 4 start-ups in the U.K. and 5 start-ups in the U.S. The companies include MultiplAI Health LTD.; BiotaX Labs LTD.; Mitra Bio Limited; Broken String Biosciences Limited; Flightpath Biosciences, Inc.; Doloromics Inc.; Oshun Medical Inc.; Parallel Health Inc.; and Rubik Therapeutics, Inc. Illumina Accelerator is an initiative through which selected startups can access to seed investment, genomics expertise, and Illumina sequencing systems and reagents and seek business guidance.

he bioinformatics application segment is expected to expand at the fastest CAGR from 2021 to 2028 owing to the increasing adoption of these tools for analyzing complex sequencing data. By technology, nanobiotechnology is expected to expand at a lucrative growth rate of 16.8% over the forecast period owing to the growing focus on nanotechnologies for efficient drug delivery and increasing research using this technology.

Supportive government initiatives are significantly contributing to market growth. For instance, in September 2020, the Government of India supported research institutes in agriculture biotechnology, including organic farming. Since the last 3 years, around USD 42.67 million had been invested to support this endeavor.

Moreover, the emergence of the SARS-COV-2 infection is driving the market. Companies are developing new solutions for combating the pandemic situation. For instance, in December 2020, Thermo Fisher Scientific Inc. announced CE-marking for TaqPath COVID-19 that can be used to perform in-vitro diagnosis of SARS-CoV-2, respiratory syncytial virus (RSV) A/B, and influenza A/B infections. The new kit will help in the detection and differentiation between diseases that have similar clinical symptoms.

Biotechnology Market Report Highlights

  • The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure
  • The DNA sequencing technology segment held the second-largest share in 2020 owing to its growing penetration in the development of precision medicines
  • North America held the largest share of 44.19% in 2020. Companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry
  • For instance, in February 2021, Waters Corporation launched Waters ACQUITY PREMIER Solution. It is a next-generation liquid chromatography solution for improving analytical data quality
  • Asia Pacific is expected to expand at the fastest CAGR of 16.8% from 2021 to 2028 owing to favorable government initiatives and changes in drug approval regulations in India and China
Please note The report will be updated with the latest data and delivered to you within 2-3 business days.


Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Industry Outlook, Trends & Scope
3.1 Market Trends & Outlook
3.2 Market Segmentation & Scope
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Declining prices of DNA sequencing
3.3.1.2 Presence of favorable government initiatives
3.3.1.3 Rising demand for agro-based products
3.3.1.4 Growing demand for synthetic biology
3.3.1.5 Robust penetration of biotechnology products & techniques in the management of COVID-19
3.3.1.6 Growing healthcare expenditure triggering the development of effective PM diagnostic & therapeutic procedure for cancer
3.4.2 Market restraint analysis
3.4.2.1 Ethical issues related to clinical trials
3.4.2.2 Risks associated with GM organisms and crops
3.4.2.3 Challenges associated with NGS implementation
3.4 Penetration & Growth Prospect Mapping for Technology, 2020
3.5 Company Market Share Analysis
3.6 Biotechnology -SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.7 Industry Analysis - Porter’s
3.8 COVID-19 Impact Analysis
3.8.1 Challenge Analysis
3.8.2 Opportunities Analysis
3.8.3 Key Development & Market Initiatives
Chapter 4 Market Categorization: Technology Estimates & Trend Analysis
4.1 Biotechnology Market: Technology Movement Analysis
4.2 Nanobiotechnology
4.2.1 Global Nanobiotechnology Market, 2017 - 2028 (USD Billion)
4.3 Tissue Engineering and Regeneration
4.3.1 Global Tissue Engineering and Regeneration Market, 2017 - 2028 (USD Billion)
4.4 DNA Sequencing
4.4.1 Global DNA Sequencing Market, 2017 - 2028 (USD Billion)
4.5 Cell-based Assays
4.5.1 Global Cell-based Assays Market, 2017 - 2028 (USD Billion)
4.6 Fermentation
4.6.1 Global Fermentation Market, 2017 - 2028 (USD Billion)
4.7 PCR Technology
4.7.1 Global PCR Technology Market, 2017 - 2028 (USD Billion)
4.8 Chromatography
4.8.1 Global Chromatography Instruments Market, 2017 - 2028 (USD Billion)
4.9 Others
4.9.1 Global Other Technologies Market, 2017 - 2028 (USD Billion)
Chapter 5 Market Categorization: Application Estimates & Trend Analysis
5.1 Biotechnology Market: Application Movement Analysis
5.2 Health
5.2.1 Global Health Biotechnology Market, 2017 - 2028 (USD Billion)
5.3 Food & Agriculture
5.3.1 Global Agriculture Biotechnology Market, 2017 - 2028 (USD Billion)
5.4 Natural Resources & Environment
5.4.1 Global Natural Resources & Environment Market, 2017 - 2028 (USD Billion)
5.5 Industrial Processing
5.5.1 Global Industrial Processing Market, 2017 - 2028 (USD Billion)
5.6 Bioinformatics
5.6.1 Global Bioinformatics Market, 2017 - 2028 (USD Billion)
5.7 Others
5.7.1 Global Other Applications Market, 2017 - 2028 (USD Billion)
Chapter 6 Market Categorization: Regional Estimates & Trend Analysis, by Application & Technology
6.1 Biotechnology Market Share by Region, 2020 & 2028
6.2 North America
6.2.1 North America Biotechnology Market, 2017 - 2028 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.2.2.2 U.S. biotechnology market, by application, 2017 - 2028 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.2.3.2 Canada biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3 Europe
6.3.1 Europe Biotechnology Market, 2017 - 2028 (USD Billion)
6.3.2 Germany
6.3.2.1 Germany biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.2.2 Germany biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.3 U.K.
6.3.3.1 U.K. biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.3.2 U.K. biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.4 France
6.3.4.1 France biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.4.2 France biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.5 Spain
6.3.5.1 Spain biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.5.2 Spain biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.6 Italy
6.3.6.1 Italy biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.6.2 Italy biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Biotechnology Market, 2017 - 2028 (USD Billion)
6.4.2 China
6.4.2.1 China biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.2.2 China biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.3 Japan
6.4.3.1 Japan biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.3.2 Japan biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.4 India
6.4.4.1 India biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.4.2 India biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.5 South Korea
6.4.5.1 South Korea biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.5.2 South Korea biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.6 Australia
6.4.6.1 Australia biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.6.2 Australia biotechnology market, by application, 2017 - 2028 (USD Billion)
6.5 Latin America
6.5.1 Latin America Biotechnology Market, 2017 - 2028 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.5.2.2 Brazil biotechnology market, by application, 2017 - 2028 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.5.3.2 Mexico biotechnology market, by application, 2017 - 2028 (USD Billion)
6.6 Middle East & Africa
6.6.1 Middle East & Africa Biotechnology Market, 2017 - 2028 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.6.2.2 South Africa biotechnology market, by application, 2017 - 2028 (USD Billion)
6.6.3 Saudi Arabia
6.6.2.1 Saudi Arabia biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.6.2.2 Saudi Arabia biotechnology market, by application, 2017 - 2028 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Gilead
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 AstraZeneca
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 CELGENE CORPORATION
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Biogen
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Abbott Laboratories
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Amgen, Inc.
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Novo Nordisk A/S
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Merck & Co.
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Johnson & Johnson
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Novartis AG
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Sanofi Aventis
7.3.11.1 Company Overview
7.3.11.2 Financial Performance
7.3.11.3 Product Benchmarking
7.3.11.4 Strategic Initiatives
7.3.12 F. Hoffmann-La Roche Ltd.
7.3.12.1 Company Overview
7.3.12.2 Financial Performance
7.3.12.3 Product Benchmarking
7.3.12.4 Strategic Initiatives
7.3.13 Pfizer, Inc.
7.3.13.1 Company Overview
7.3.13.2 Financial Performance
7.3.13.3 Product Benchmarking
7.3.14.4 Strategic Initiatives
7.3.14 Lonza
7.3.14.1 Company Overview
7.3.14.2 Financial Performance
7.3.14.3 Product Benchmarking
7.3.14.4 Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings